Connection

Chih-Cheng Lai to Bacterial Infections

Back to Details
This is a "connection" page, showing publications Chih-Cheng Lai has written about Bacterial Infections.
Chih-Cheng Lai
Connection Strength
0.795
Bacterial Infections
  1. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021 Apr; 57(4):106324.
    View in: PubMed
    Score: 0.332
  2. The Safety of Eravacycline in the Treatment of Acute Bacterial Infection. Clin Infect Dis. 2020 06 10; 70(12):2750-2751.
    View in: PubMed
    Score: 0.314
  3. Predominance of methicillin-resistant Staphylococcus aureus in the residents and environments of long-term care facilities in Taiwan. J Microbiol Immunol Infect. 2019 Feb; 52(1):62-74.
    View in: PubMed
    Score: 0.067
  4. Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan. J Microbiol Immunol Infect. 2017 Apr; 50(2):133-144.
    View in: PubMed
    Score: 0.062
  5. Tocilizumab for severe COVID-19: a systematic review and meta-analysis. Int J Antimicrob Agents. 2020 Sep; 56(3):106103.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.